The Actavis deal and balance sheet considerations TEVA unnecessarily bet very big on Actavis, spending nearly $40 billion on it at or near the top of the generic pricing cycle. This has left the company with a highly leveraged balance sheet. swimwear sale swimwear sale gyssnv88990
Comments:
The Actavis deal and balance sheet considerations TEVA unnecessarily bet very big
on Actavis, spending nearly $40 billion on it at or near the top of the generic pricing cycle.
This has left the company with a highly leveraged balance sheet.
swimwear sale swimwear sale gyssnv88990